Japan, Jan. 20 -- ALNYLAM PHARMACEUTICALS INC has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN.' Other related details are as follows:
Application Number: JP,2024-091123
Category (FI): C12N15/113@Z,A61P43/00,A61P1/16,A61K31/713,A61K48/00,A61K47/28,C12N15/63@Z,C12N5/10,C12N15/88@Z,A61K47/24,A61K47/22,A61K9/127,A61K47/10
Stage: Grant (IP right granted following substantive examination.)
Filing Date: June 5, 2024
Publication Date: Aug. 27, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
